This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Haematology
Haematology
MabThera improves adult leukaemia patient responses
Rivaroxaban “superior to enoxaparin for VTE”
Pharmion to present key haematology product data
Risk assessed for fatal PE post VTE therapy
Heart issue halts Merck leukaemia drug trial
FDA approves anaemia drug Mircera
FDA releases new warnings on ESAs
Advances in the treatment of iron overload: focus on deferasirox
Use of human recombinant coagulation factor VIIa (rFVIIa) in patients with severe bleeding
EMEA approves Aranesp for child anaemia in CKD
FDA panel clears blood-clot drug to stay on US market
Blood-clot protein gets US go-ahead
« Previous
1
…
27
28
29
30
31
…
34
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: